Back to Search
Start Over
Quantifying prion disease penetrance using large population control cohorts
- Source :
- Science Translational Medicine, 8(322):322ra9. American Association for the Advancement of Science, Science Translational Medicine, 8(322). American Association for the Advancement of Science, Minikel, E V, Vallabh, S M, Lek, M, Estrada, K, Samocha, K E, Sathirapongsasuti, J F, McLean, C Y, Tung, J Y, Yu, L P C, Gambetti, P, Blevins, J, Zhang, S, Cohen, Y, Chen, W, Yamada, M, Hamaguchi, T, Sanjo, N, Mizusawa, H, Nakamura, Y, Kitamoto, T, Collins, S J, Boyd, A, Will, R G, Knight, R, Ponto, C, Zerr, I, Kraus, T F J, Eigenbrod, S, Giese, A, Calero, M, De Pedro-Cuesta, J, Haïk, S, Laplanche, J L, Bouaziz-Amar, E, Brandel, J P, Capellari, S, Parchi, P, Poleggi, A, Ladogana, A, O'Donnell-Luria, A H, Karczewski, K J, Marshall, J L, Boehnke, M, Laakso, M, Mohlke, K L, Kähler, A, Chambert, K, McCarroll, S, Sullivan, P F, Hultman, C M, Purcell, S M, Sklar, P, Van Der Lee, S J, Rozemuller, A, Jansen, C, Hofman, A, Kraaij, R, Van Rooij, J G J, Ikram, M A, Uitterlinden, A G, van Duijn, C M, Daly, M J & MacArthur, D G 2016, ' Quantifying prion disease penetrance using large population control cohorts ', Science Translational Medicine, vol. 8, no. 322, 322ra9 . https://doi.org/10.1126/scitranslmed.aad5169
- Publication Year :
- 2015
- Publisher :
- American Association for the Advancement of Science, 2015.
-
Abstract
- More than 100,000 genetic variants are reported to cause Mendelian disease in humans, but the penetrance-the probability that a carrier of the purported disease-causing genotype will indeed develop the disease-is generally unknown. We assess the impact of variants in the prion protein gene (PRNP) on the risk of prion disease by analyzing 16,025 prion disease cases, 60,706 population control exomes, and 531,575 individuals genotyped by 23andMe Inc. We show that missense variants in PRNP previously reported to be pathogenic are at least 30 times more common in the population than expected on the basis of genetic prion disease prevalence. Although some of this excess can be attributed to benign variants falsely assigned as pathogenic, other variants have genuine effects on disease susceptibility but confer lifetime risks ranging from < 0.1 to similar to 100%. We also show that truncating variants in PRNP have position-dependent effects, with true loss-of-function alleles found in healthy older individuals, a finding that supports the safety of therapeutic suppression of prion protein expression.
- Subjects :
- 0301 basic medicine
PROTEIN GENE MUTATION
CREUTZFELDT-JAKOB-DISEASE
animal diseases
Penetrance
Disease
Research & Experimental Medicine
R208H MUTATION
Prion Diseases
Cohort Studies
STRAUSSLER-SCHEINKER-DISEASE
0302 clinical medicine
Risk Factors
Genotype
Exome sequencing
Genetics
education.field_of_study
FATAL FAMILIAL INSOMNIA
General Medicine
11 Medical And Health Sciences
3. Good health
Medicine, Research & Experimental
UNCOMMON POLYMORPHISM RATHER
Life Sciences & Biomedicine
Prions
Population
Biology
AMYLOID PRECURSOR GENE
PRNP GENE
PRNP
03 medical and health sciences
medicine
Humans
Genetic Predisposition to Disease
Allele
TRANSGENIC MOUSE MODEL
education
Fatal familial insomnia
Science & Technology
Exome Aggregation Consortium (ExAC)
Cell Biology
06 Biological Sciences
medicine.disease
POINT MUTATION
nervous system diseases
030104 developmental biology
Case-Control Studies
Mutation
030217 neurology & neurosurgery
Subjects
Details
- Language :
- English
- ISSN :
- 19466234
- Database :
- OpenAIRE
- Journal :
- Science Translational Medicine, 8(322):322ra9. American Association for the Advancement of Science, Science Translational Medicine, 8(322). American Association for the Advancement of Science, Minikel, E V, Vallabh, S M, Lek, M, Estrada, K, Samocha, K E, Sathirapongsasuti, J F, McLean, C Y, Tung, J Y, Yu, L P C, Gambetti, P, Blevins, J, Zhang, S, Cohen, Y, Chen, W, Yamada, M, Hamaguchi, T, Sanjo, N, Mizusawa, H, Nakamura, Y, Kitamoto, T, Collins, S J, Boyd, A, Will, R G, Knight, R, Ponto, C, Zerr, I, Kraus, T F J, Eigenbrod, S, Giese, A, Calero, M, De Pedro-Cuesta, J, Haïk, S, Laplanche, J L, Bouaziz-Amar, E, Brandel, J P, Capellari, S, Parchi, P, Poleggi, A, Ladogana, A, O'Donnell-Luria, A H, Karczewski, K J, Marshall, J L, Boehnke, M, Laakso, M, Mohlke, K L, Kähler, A, Chambert, K, McCarroll, S, Sullivan, P F, Hultman, C M, Purcell, S M, Sklar, P, Van Der Lee, S J, Rozemuller, A, Jansen, C, Hofman, A, Kraaij, R, Van Rooij, J G J, Ikram, M A, Uitterlinden, A G, van Duijn, C M, Daly, M J & MacArthur, D G 2016, ' Quantifying prion disease penetrance using large population control cohorts ', Science Translational Medicine, vol. 8, no. 322, 322ra9 . https://doi.org/10.1126/scitranslmed.aad5169
- Accession number :
- edsair.doi.dedup.....345ca3279c0849399b5f2fe8df6626b2
- Full Text :
- https://doi.org/10.1126/scitranslmed.aad5169